Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Other Working Capital Changes of -$3000.0 for Q1 2026, down 113.04% year-on-year from $23000.0 in Q1 2025, and up 25.0% on a QoQ basis from -$4000.0 in Q4 2025.
Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Other Working Capital Changes for 3 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Working Capital Changes fell 113.04% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$544000.0 (down 313.33% YoY) and the FY2025 annual result came in at -$518000.0, down 328.19% from the prior year.
- Other Working Capital Changes climbed to -$3000.0 in Q1 2026 per CNTB's latest filing, from -$4000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for CNTB reached as high as $2.2 million in Q2 2025 and fell as low as -$1.6 million in Q4 2024.
- A 3-year average of $229666.7 and a median of -$42000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 560.0% in 2025 against a maximum downside of 8783.33% in 2025.
- Year by year, Other Working Capital Changes stood at -$9000.0 in 2024, then surged by 55.56% to -$4000.0 in 2025, then rose by 25.0% to -$3000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$3000.0, -$4000.0, and -$4000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Jun 30, 2025 | -533,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Sep 30, 2024 | 247,000.00 |
| Sep 30, 2024 | 247,000.00 |